newsfilter
← Latest News
GlobeNewswire·

Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results

— Strong cash position with $54.8 million of cash and cash equivalents as of June 30, 2022, expected to provide cash runway beyond August 2023 NEW YORK, N.Y. and DURHAM, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: